Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes
- DOI
- 10.1097/md.0000000000050241
- Published
- 2026-08-21
- Container
- Medicine
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/md.0000000000050241,
title = {Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes},
author = {Tae Hyeon Kim and Yerin Hwang and Selin Woo and Kyeongmin Lee and Yejun Son and Seoyoung Park and Hyunjee Kim and Ju-Young Shin and YongHyun Cho and Dahye Shin and Dosang Cho and Kyung-Jae Lee and Chang Hyun Kim and Sang Youl Rhee and Dong Keon Yon},
year = {2026},
journal = {Medicine},
doi = {10.1097/md.0000000000050241},
url = {https://doi.org/10.1097/md.0000000000050241}
}RIS
TY - JOUR TI - Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes AU - Tae Hyeon Kim AU - Yerin Hwang AU - Selin Woo AU - Kyeongmin Lee AU - Yejun Son AU - Seoyoung Park AU - Hyunjee Kim AU - Ju-Young Shin AU - YongHyun Cho AU - Dahye Shin AU - Dosang Cho AU - Kyung-Jae Lee AU - Chang Hyun Kim AU - Sang Youl Rhee AU - Dong Keon Yon PY - 2026 JO - Medicine DO - 10.1097/md.0000000000050241 UR - https://doi.org/10.1097/md.0000000000050241 ER -
APA
Kim, T. H., Hwang, Y., Woo, S., Lee, K., Son, Y., Park, S., Kim, H., Shin, J., Cho, Y., Shin, D., Cho, D., Lee, K., Kim, C. H., Rhee, S. Y., & Yon, D. K. (2026). Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes. Medicine. https://doi.org/10.1097/md.0000000000050241
Source records
- crossref · retrieved 2026-09-27T05:07:38.046Z